Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap

ClinicalTrials.gov ID: NCT02131662

Public ClinicalTrials.gov record NCT02131662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Parallel-group, Double-blind, Placebo Controlled, Multi-center Study to Assess the Efficacy and Safety of Different Doses of BAY1002670 in Subjects With Uterine Fibroids Over 3 Months

Study identification

NCT ID
NCT02131662
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bayer
Industry
Enrollment
309 participants

Conditions and interventions

Conditions

Interventions

  • BAY1002670 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2014
Primary completion
May 3, 2016
Completion
May 3, 2016
Last update posted
Dec 7, 2017

2014 – 2016

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Not listed Mesa Arizona 85209
Not listed Tucson Arizona 85712
Not listed San Diego California 92103
Not listed San Diego California 92108
Not listed Denver Colorado 80209
Not listed Southington Connecticut 06489
Not listed Washington D.C. District of Columbia 20036
Not listed Gainesville Florida 32606
Not listed Jacksonville Florida 32207
Not listed Plantation Florida 33324
Not listed South Miami Florida 33143
Not listed Sandy Springs Georgia 30328
Not listed Naperville Illinois 60540
Not listed Newburgh Indiana 47630
Not listed Marrero Louisiana 70072
Not listed Lincoln Nebraska 68510
Not listed Moorestown New Jersey 08057
Not listed Neptune City New Jersey 07753
Not listed New Brunswick New Jersey 08901
Not listed New York New York 10038
Not listed Durham North Carolina 27713
Not listed Raleigh North Carolina 27612
Not listed Cleveland Ohio 44195
Not listed Columbus Ohio 43231
Not listed Portland Oregon 97239-3011
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19114
Not listed Pittsburgh Pennsylvania 15206
Not listed Pittsburgh Pennsylvania 15213-3180
Not listed Chattanooga Tennessee 37404
Not listed Dallas Texas 75231
Not listed Frisco Texas 75035
Not listed Houston Texas 77030
Not listed Houston Texas 77054
Not listed Norfolk Virginia 23507
Not listed Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02131662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02131662 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →